DGAP-News

GLOBAL BIOENERGIES REPORTS 2013 FINAL RESULTS - Seite 2

expected in 2014 in alignment with industrialization efforts".

Marc Delcourt, CEO of Global Bioenergies concludes: "Revenues fluctuate
from year to year and are still limited. They will only soar after the
launch of the commercial phase, once the first industrial pilots
test-campaigns are carried out".

- Key facts and recent events

Partnership with the car manufacturer Audi

Global Bioenergies has announced on January 21st, 2014 the signature of a
partnership with the German car manufacturer Audi to develop the production
of bio-sourced isooctane, a high performance gasoline fuel, from biological
isobutene.

Construction of a second industrial pilot in Germany financially supported
by the German Federal Ministry of Education and Research

Global Bioenergies has announced on November 20th, 2013 having been awarded
by the BMBF, the German Ministry for Research, a 5.7 million euros grant to
build an industrial pilot on the refinery site of Leuna and to finalize
there the industrialization of the isobutene process. This second pilot
will allow to continue the studies initiated from end 2014 on its first
pilot in France. The engineering of this second pilot is in the hands of
the Engineering division of The Linde Group, a global leader in the field
of industrial gases and engineering.

23 million euros capital increase by public offering on July 16th, 2013

Global Bioenergies has called upon the market by way of public offering in
France and national and international private placement. The operation has
been a great success (oversubscribed at 143%) and has been accomplished by
complete exercise of the extension clause based on a share price of 24.80
euros. About 40 institutional investors have subscribed to the offering as
well as numerous private investors.

Industrial pilot for the bioproduction of isobutene supported by the
Investissements d'Avenir program

On June 4th, 2013, Global Bioenergies has announced having successfully
carried out tests in its laboratory scale pilot and therefore launched the
next phase dedicated to the installation of an industrial pilot to carry
out tests at the 500 liters scale. This new phase in process
industrialization has begun during the second semester 2013 and will be
supported by a 5.2 million euros State financing via the Investissements
d'Avenir program. This project is carried out in collaboration with Arkema
and the CNRS.

Global Bioenergies is eligible to the PEA-PME instrument

Global Bioenergies meets the eligibility criteria of the PEA-PME equity
savings plan detailed in the French Decree of Application N 2014-283
issued on March 4th, 2014. The PEA-PME beneficiates from the same fiscal